hepatoprotect
induc
synthet
muramyl
peptid
investig
use
model
lethal
murin
mous
hepat
viru
infect
mdp
nonpyrogen
analog
murametid
inhibit
steep
elev
serum
transaminas
induc
irrespect
whether
immunomodul
administ
infect
signific
proport
mdp
murametidetr
anim
contrast
control
surviv
infect
histopatholog
examin
liver
reveal
mark
necrosi
hepat
parenchym
cell
infiltr
inflammatori
cell
control
mdptreat
anim
due
hepat
virus
mycobacterium
tuberculosi
endem
southeast
asia
amongst
refuge
region
studi
immun
respons
infect
indochines
refuge
show
signific
associ
reactiv
purifi
tuberculin
protein
deriv
ppd
presenc
hepat
antigen
mcglynn
lustbad
london
person
posit
ppd
skin
test
tend
hbeag
neg
suggest
mycobacterium
tuberculosi
infect
may
affect
outcom
viral
hepat
mous
hepat
viru
type
belong
group
coronavirus
parenter
administr
suscept
mice
caus
fatal
hepat
necrosi
culmin
death
within
matter
day
hepat
necrosi
liber
sever
enzym
usual
present
intracellularli
within
liver
blood
circul
elev
serum
transaminas
import
biochem
manifest
human
murin
viral
hepat
use
diagnost
marker
liver
damag
measur
serum
alanin
aminotransferas
indochines
refuge
show
normal
transaminas
level
ppdposit
person
compar
ppdneg
individu
mcglynn
et
al
would
consider
interest
protect
virusmedi
liver
damag
associ
tuberculosi
infect
could
duplic
immunomodul
mycobacteri
origin
mycobacteria
contain
cell
wall
nacetylmuramyllalanyldisoglutamin
mdp
small
glycopeptid
repres
minim
structur
essenti
bacteri
adjuvant
synthet
mdp
analog
endow
multifari
properti
includ
stimul
nonspecif
resist
viral
pathogen
chedid
alreadi
report
mdp
combin
trehalos
dimycol
could
induc
resist
influenza
viru
infect
masihi
brehmer
lang
ribi
sever
mdp
analog
like
ubiquinon
masihi
brehmer
azuma
lang
miiller
seryl
aminobutyryl
masihi
brehmer
lang
ribi
schwartzman
confer
longterm
resist
aerogen
influenza
viru
combin
trehalos
dimycol
subsequ
mdp
analog
shown
induc
protect
variou
strain
influenza
dietrich
hochkeppel
luka
herp
simplex
viru
dietrich
et
al
koff
showalt
hampar
fidler
vaccinia
viru
ikeda
negishi
nishimura
sendai
viru
yamamura
ishihara
hamada
yamamoto
azuma
combin
interferoninduc
semliki
forest
viru
georg
jain
gupta
anand
mdp
also
protect
rat
hepatocyt
vitro
toxic
effect
acrolein
chloroform
carbon
tetrachlorid
decreas
serum
transaminas
farghali
machkovfi
kameinikov
jank
mgek
present
studi
effect
mdp
nonpyrogen
analog
murametid
biochem
paramet
investig
use
model
lethal
routin
viru
infect
k
noel
masihi
el
al
nuclei
liver
cell
isol
use
techniqu
previous
describ
blobel
potter
adpr
transferas
activ
measur
presenc
dnase
kidwel
burdett
five
sixweek
old
nmri
mice
purchas
zentralinstitut
fur
versuchstier
hannov
frg
histolog
studi
mice
given
salin
mg
mdp
h
h
h
infect
liver
remov
day
viral
infect
fix
formalin
histolog
section
stain
hematoxylin
eosin
mdp
analog
murametid
synthes
p
lefranci
institut
choay
pari
franc
lefranci
derrien
jamet
choay
leder
audibert
parant
parant
chedid
desir
amount
muramyl
peptid
dissolv
pyrogenfre
physiolog
salin
substanc
administ
intraperiton
ip
rout
passag
ip
young
nmri
mice
liver
remov
day
infect
homogen
ml
mediumliv
use
tissu
grinder
supernat
obtain
centrifug
dilut
passag
mous
lcell
mark
cytopath
effect
could
observ
tissu
cultur
lcell
use
supernat
dilut
threeday
old
cultur
infect
dilut
supern
frozen
thaw
three
time
supern
obtain
centrifug
store
liquid
nitrogen
variou
dilut
inject
ip
mice
determin
lethal
dose
half
millilit
dilut
inject
ip
consist
gave
ld
old
nmri
mice
use
experi
got
gpt
enzym
activ
present
nonhemolyt
sera
collect
differ
interv
determin
use
standard
method
bergmey
reagent
test
purchas
boehring
mannheim
frg
enzym
activ
present
muml
thirti
anim
administ
singl
dose
mdp
ip
rout
effect
mdp
liver
enzym
determin
group
pretreat
mice
twenti
mice
mdppretreat
group
normal
mice
inject
salin
infect
ip
h
mdp
administr
sera
collect
everyday
four
day
result
enzym
activ
present
fig
serum
got
gpt
activ
induc
administr
mdp
alon
contrast
infect
induc
increas
got
gpt
activ
day
enzym
level
elev
even
day
time
period
mani
anim
die
pretreat
mdp
greatli
reduc
rise
got
gpt
level
observ
infect
sixteen
mice
given
mdp
h
h
h
h
infect
anoth
group
mice
similarli
treat
mdp
receiv
viral
infect
third
group
mice
receiv
infect
sera
collect
everi
day
day
infect
result
present
fig
show
multipl
administr
mdp
alon
affect
liver
transaminas
mdp
given
infect
could
inhibit
induct
serum
got
gpt
fig
effect
mdp
potent
nonpyrogen
analog
murametid
investig
higher
dosag
twentyeight
anim
given
mg
mdp
mg
murametid
h
h
h
infect
eight
anim
viru
control
fig
nonpyrogen
murametid
activ
inhibit
got
gpt
induct
fig
neither
mdp
alon
murametid
alon
induc
liver
enzym
activ
dosag
activ
adpr
transferas
nuclei
liver
cell
increas
infect
tabl
contrast
treatment
mg
mdp
h
infect
result
small
reduct
adpr
transferas
activ
addit
treatment
mdp
h
h
postinfect
adpr
transferas
activ
h
h
one
milligram
mdp
murametid
administ
three
time
infect
confer
signific
protect
respect
treat
mice
compar
survivor
control
group
fig
lower
dose
mdp
given
prior
infect
significantli
affect
mortal
data
shown
mice
infect
develop
extens
necrot
lesion
around
central
arteri
day
fig
mark
necrosi
hepat
parenchym
cell
accompani
infiltr
inflammatori
cell
contrast
mdptreat
anim
exhibit
strong
suppress
hepat
necrosi
lack
cellular
infiltr
day
infect
fig
result
present
studi
demonstr
hepatoprotect
activ
synthet
muramyl
peptid
viral
hepat
mdp
murametid
k
noel
el
al
could
prevent
steep
elev
serum
got
gpt
transaminas
level
induc
infect
inhibit
got
gpt
enzym
activ
observ
least
h
infect
irrespect
whether
mdp
given
infect
histopatholog
examin
liver
reveal
mark
protect
confer
mdp
treatment
contrast
extens
necrosi
hepat
parenchym
cell
control
anim
certain
chemic
caus
profound
liver
damag
abil
mdp
protect
rat
hepatocyt
vitro
toxic
effect
acrolein
chloroform
carbon
tetrachlorid
describ
serum
aspart
alanin
transaminas
detect
h
ip
carbon
tetrachlorid
administr
rat
could
also
decreas
intraven
mdp
pretreat
farghali
et
al
abil
protect
liver
damag
viral
chemic
agent
may
constitut
import
properti
immunomodul
like
mdp
nicotinamid
adenin
dinucleotid
nad
function
import
catalyt
coenzym
oxid
reduct
reaction
addit
nad
also
particip
certain
biolog
process
like
adenoribosyl
substrat
enzym
adpr
transferas
cleav
nad
subsequ
adenoribosyl
specif
protein
nadadenoribosyl
metabol
involv
quit
number
process
like
dna
repair
differenti
enzym
regul
etc
activ
adpr
transferas
earli
stage
infect
somewhat
lower
mdptreat
anim
control
experi
current
progress
defin
role
nad
metabol
damag
liver
mechan
involv
protect
confer
mdp
fulli
elucid
yet
mdp
administr
increas
incorpor
radiolabel
palmit
acid
hepatocyt
phospholipid
suggest
stabil
effect
hepatocyt
farghali
machkovfi
juli
buchar
jank
mgek
addit
stimul
nonspecif
resist
mechan
mdp
may
respons
part
protect
infect
clearanc
colloid
carbon
impair
gledhil
bilbey
niven
sinc
mdp
sever
analog
enhanc
clearanc
colloid
carbon
particl
blood
reticuloendotheli
system
frasersmith
water
matthew
activ
varieti
macrophag
function
lecler
chedid
induc
dysfunct
may
balanc
mdp
protect
role
endogen
interferon
suggest
interferon
induct
infect
resist
suscept
strain
mice
find
prior
administr
antiinterferon
serum
caus
acceler
mortal
virelizi
muramyl
peptid
augment
viral
interferon
product
sakuma
azuma
yoshida
murin
hepat
stimul
nk
cell
activ
liver
talmadg
schneider
collin
phillip
herberman
wiltrout
spleen
masihi
lang
rohdeschulz
activ
cytotox
properti
murin
kupfer
cell
xu
fidler
